Thermo Fisher Scientific CILP Polyclonal Antibody

Applications

• Western Blot (WB): 1–10 µg/mL

Product Specifications

Product Specific Information

• In direct ELISAs, less than 1% cross-reactivity with recombinant human CILP-1 C-terminal peptide is observed.
• Reconstitute at 0.2 mg/mL in sterile PBS.

Target Information

Major alterations in the composition of the cartilage extracellular matrix occur in joint disease, such as osteoarthrosis.
This gene encodes the cartilage intermediate layer protein activity.
The full-length and the N-terminal domain of this protein were shown to function as an IGF-1 antagonist.
An allelic variant of this gene has been associated with lumbar disc disease.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.